Suppr超能文献

T4期肺癌的根治性切除术。

Radical resections for T4 lung cancer.

作者信息

Rice Thomas W, Blackstone Eugene H

机构信息

Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic Foundation, OH 44195, USA.

出版信息

Surg Clin North Am. 2002 Jun;82(3):573-87. doi: 10.1016/s0039-6109(02)00017-8.

Abstract

T4 lung cancers are a heterogeneous group of locally advanced lung cancers. Treatment is palliative for the majority of patients, ranging from supportive care to chemoradiotherapy. In certain patients, however, surgery is beneficial and may be curative. Patients with T4N0M0 cancers invading the distal trachea, carina, left atrium, aorta, superior vena cava, or vertebral bodies may be surgical candidates. Radical resections of these T4 lung cancers have potential for cure if no mediastinal lymph node metastases (N2 or N3) occur and if resection is complete. Increased postoperative mortality exists and extends beyond 30 days, as evidenced by a 30-day mortality of 8% and a 90-day mortality of 18%. Improved palliation (median survival of 19 months) and cure (31% five-year survival) are possible in patients who meet the criteria, who undergo radical resection, and who are followed by physicians in facilities with special interests in extended resections. The use of induction therapy and surgery in T4 patients may further increase survival and the number of T4 patients in whom radical resection is possible. Radical resections are contraindicated in patients with T4 lung cancers associated with malignant pleural effusions. Unfortunately, these patients have the worst prognosis. If surgical palliation is an option, only pulmonary resection with pleurectomy and not pleuropneumonectomy should be considered. In contrast, lung cancers with the best prognosis are those T4 tumors diagnosed because of a satellite tumor nodule within the same lobe. Because radical resections are usually not required, operative mortality is not increased. Five-year survival in patients with satellite intralobar tumor nodules without mediastinal nodal metastases is comparable to survival of highly selected T4N0M0 patients who undergo radical resection. These two extremes of T4 lung cancers, malignant pleural effusion and satellite intralobar tumor nodules, generally are not considered for or do not require radical resections. It is debatable that the definition of T4 should include these entities.

摘要

T4期肺癌是一组异质性的局部晚期肺癌。大多数患者的治疗是姑息性的,范围从支持治疗到放化疗。然而,在某些患者中,手术是有益的,甚至可能治愈。T4N0M0期肿瘤侵犯远端气管、隆突、左心房、主动脉、上腔静脉或椎体的患者可能是手术候选者。如果没有纵隔淋巴结转移(N2或N3)且切除完整,这些T4期肺癌的根治性切除有治愈的可能。术后死亡率增加且超过30天,30天死亡率为8%,90天死亡率为18%就证明了这一点。符合标准、接受根治性切除且在对扩大切除有特殊兴趣的机构中由医生随访的患者,有可能改善姑息治疗效果(中位生存期19个月)并实现治愈(五年生存率31%)。在T4期患者中使用诱导治疗和手术可能会进一步提高生存率,并增加可能进行根治性切除的T4期患者数量。伴有恶性胸腔积液的T4期肺癌患者禁忌进行根治性切除。不幸的是,这些患者预后最差。如果手术姑息是一种选择,仅应考虑肺切除加胸膜切除术,而不是胸膜肺切除术。相比之下,预后最好的肺癌是那些因同一肺叶内卫星肿瘤结节而被诊断为T4期的肿瘤。由于通常不需要根治性切除,手术死亡率不会增加。无纵隔淋巴结转移的肺叶内卫星肿瘤结节患者的五年生存率与接受根治性切除的高度选择的T4N0M0期患者的生存率相当。T4期肺癌的这两个极端情况,即恶性胸腔积液和肺叶内卫星肿瘤结节,一般不考虑进行或不需要进行根治性切除。T4的定义是否应包括这些实体存在争议。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验